Comparison of preclinical efficacy of immunotherapies against HPV-induced cancers

• Prif Awduron: Anastasia Demidova (Awdur), Laëtitia Douguet (Awdur), Ingrid Fert (Awdur), Yu Wei (Awdur), Pierre Charneau (Awdur), Laleh Majlessi (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: Taylor & Francis Group, 2024-12-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Introduction Persistent infections with the human papilloma viruses, HPV16 and HPV18, are associated with multiple cancers. Although prophylactic vaccines that induce HPV-neutralizing antibodies are effective against primary infections, they have no effect on HPV-mediated malignancies against which...